Professor Deborah Ferrington, University of Minnesota.

1:00pm - 2:00pm / Wednesday 18th September 2019 / Venue: William Henry Duncan Apex Building
Type: Seminar / Category: Research / Series: Institute of Ageing & Chronic Disease seminar series
  • 0151 794 9003
  • Suitable for: Staff and students
  • Admission: Free to staff and students
  • Add this event to my calendar
    (?)

    When you click on "Add this event to my calendar" your browser will download an ics file.

    Microsoft Outlook: Download the file, then you may be able to click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open, then Import. Select "Import an iCalendar (.ic or vCalendar file (.vcs)" then click on Next. Find the .ics file and click on OK.

    Google Calendar: download the file, then go into your calendar. On the right where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.

    Apple Calendar: download the file, then you can either drag it to Calendar or import the file by going to File > Import > Import and choosing the .ics file.

Deborah Ferrington, Professor and Director of Research, Department of Ophthalmology and Visual Neurosciences, University of Minnesota
‘Matching Therapy to the Defect: Targeting the Mitochondria to Treat Age-Related Macular Degeneration.’
Dr Ferrington’s research is focused on investigating the molecular changes that occur with retinal aging and age-related macular degeneration (AMD), the number one cause of blindness among adults in the developed world. The experimental approach to investigate AMD pathogenesis has been to study changes in cellular composition and function in human donor eyes at progressive stages of AMD using a combination of proteomic and molecular biology techniques, as well as performing functional testing on RPE cultures. Results from multiple analyses led to the unique observation that the mitochondria in the retinal pigment epithelium (RPE) are negatively impacted by the disease and thus, mitochondria are a potential molecular target for therapy.
Host: Luminita Paraoan